These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Key Determinants in the Pathogenesis of Equine Herpesvirus 1 and 4 Infections. Hussey GS Vet Pathol; 2019 Sep; 56(5):656-659. PubMed ID: 31394999 [No Abstract] [Full Text] [Related]
23. Towards a vaccine against equine herpesvirus 1. Sabine M; Whalley JM Aust Vet J; 1989 Dec; 66(12):403-4. PubMed ID: 2559691 [No Abstract] [Full Text] [Related]
24. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals. Purdy CW; Porter RC; Ford SJ Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062 [No Abstract] [Full Text] [Related]
25. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus. Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488 [TBL] [Abstract][Full Text] [Related]
26. Identification of equine herpesviruses 1 and 4 by polymerase chain reaction. Varrasso A; Dynon K; Ficorilli N; Hartley CA; Studdert MJ; Drummer HE Aust Vet J; 2001 Aug; 79(8):563-9. PubMed ID: 11599819 [TBL] [Abstract][Full Text] [Related]
27. Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)--masters of co-evolution and a constant threat to equids and beyond. Ma G; Azab W; Osterrieder N Vet Microbiol; 2013 Nov; 167(1-2):123-34. PubMed ID: 23890672 [TBL] [Abstract][Full Text] [Related]
28. A brief review of studies of bovine and equine herpesviruses. Studdert MJ Aust Vet J; 1989 Dec; 66(12):401-2. PubMed ID: 2559690 [No Abstract] [Full Text] [Related]
29. Equid herpesvirus 1 is neurotropic in mice, but latency from which infectious virus can be reactivated does not occur. Iqbal J; Edington N Acta Vet Hung; 2002; 50(1):117-29. PubMed ID: 12061230 [TBL] [Abstract][Full Text] [Related]
30. Dual infections of equine herpesvirus 1 and equine arteritis virus in equine respiratory mucosa explants. Zhao J; Negussie H; Laval K; Poelaert KC; Nauwynck HJ Virus Res; 2016 Jul; 220():104-11. PubMed ID: 27117322 [TBL] [Abstract][Full Text] [Related]
35. Vaccination of mares against equine herpesvirus-1. Pickles AC Vet Rec; 1992 Feb; 130(8):167-8. PubMed ID: 1314446 [No Abstract] [Full Text] [Related]
36. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469 [TBL] [Abstract][Full Text] [Related]
37. Antiviral agents against equid alphaherpesviruses: Current status and perspectives. Vissani MA; Thiry E; Dal Pozzo F; Barrandeguy M Vet J; 2016 Jan; 207():38-44. PubMed ID: 26654843 [TBL] [Abstract][Full Text] [Related]
38. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges. Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066 [TBL] [Abstract][Full Text] [Related]
39. Equine herpesvirus 1 and 4 infections: an update. van Maanen C Vet Q; 2002 Jun; 24(2):58-78. PubMed ID: 12095082 [TBL] [Abstract][Full Text] [Related]
40. Antiherpetic Drugs in Equine Medicine. Maxwell LK Vet Clin North Am Equine Pract; 2017 Apr; 33(1):99-125. PubMed ID: 28325183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]